STERIS (STE) Projected to Post Earnings on Wednesday

STERIS (NYSE:STE) is expected to be posting its Q2 2026 results after the market closes on Wednesday, November 5th. Analysts expect STERIS to post earnings of $2.37 per share and revenue of $1.4303 billion for the quarter. Individuals are encouraged to explore the company’s upcoming Q2 2026 earningoverview page for the latest details on the call scheduled for Thursday, November 6, 2025 at 9:00 AM ET.

STERIS (NYSE:STE) last issued its quarterly earnings results on Wednesday, August 6th. The medical equipment provider reported $2.34 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.32 by $0.02. The company had revenue of $1.40 billion for the quarter, compared to the consensus estimate of $1.36 billion. STERIS had a return on equity of 14.17% and a net margin of 11.61%.STERIS’s revenue for the quarter was up 8.8% on a year-over-year basis. During the same quarter in the prior year, the business posted $2.03 earnings per share. On average, analysts expect STERIS to post $9 EPS for the current fiscal year and $10 EPS for the next fiscal year.

STERIS Stock Performance

Shares of STE stock opened at $237.21 on Tuesday. The company has a market capitalization of $23.36 billion, a P/E ratio of 36.33 and a beta of 1.01. The business’s 50 day moving average is $243.56 and its two-hundred day moving average is $238.26. The company has a current ratio of 2.22, a quick ratio of 1.53 and a debt-to-equity ratio of 0.27. STERIS has a 12-month low of $200.98 and a 12-month high of $253.00.

STERIS Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Thursday, December 18th. Shareholders of record on Tuesday, November 18th will be given a dividend of $0.63 per share. The ex-dividend date is Tuesday, November 18th. This represents a $2.52 dividend on an annualized basis and a yield of 1.1%. STERIS’s dividend payout ratio is currently 38.59%.

Insider Activity

In related news, CEO Daniel A. Carestio sold 159 shares of STERIS stock in a transaction that occurred on Monday, October 6th. The stock was sold at an average price of $241.82, for a total transaction of $38,449.38. Following the transaction, the chief executive officer owned 51,096 shares in the company, valued at approximately $12,356,034.72. This trade represents a 0.31% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, CAO Karen L. Burton sold 7,900 shares of STERIS stock in a transaction that occurred on Monday, August 11th. The stock was sold at an average price of $241.73, for a total value of $1,909,667.00. Following the transaction, the chief accounting officer owned 5,994 shares in the company, valued at approximately $1,448,929.62. The trade was a 56.86% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders have sold a total of 18,868 shares of company stock valued at $4,585,389 in the last 90 days. 1.07% of the stock is owned by insiders.

Hedge Funds Weigh In On STERIS

A number of institutional investors have recently added to or reduced their stakes in STE. Orbis Allan Gray Ltd lifted its position in STERIS by 36.0% during the second quarter. Orbis Allan Gray Ltd now owns 2,100,099 shares of the medical equipment provider’s stock worth $504,486,000 after buying an additional 556,088 shares in the last quarter. AQR Capital Management LLC lifted its position in STERIS by 130.6% during the second quarter. AQR Capital Management LLC now owns 424,647 shares of the medical equipment provider’s stock worth $101,682,000 after buying an additional 240,497 shares in the last quarter. Worldquant Millennium Advisors LLC lifted its position in STERIS by 195.7% during the second quarter. Worldquant Millennium Advisors LLC now owns 206,464 shares of the medical equipment provider’s stock worth $49,597,000 after buying an additional 136,653 shares in the last quarter. Goldman Sachs Group Inc. raised its position in STERIS by 32.3% in the first quarter. Goldman Sachs Group Inc. now owns 242,732 shares of the medical equipment provider’s stock valued at $55,015,000 after purchasing an additional 59,264 shares during the period. Finally, Bank of America Corp DE raised its position in STERIS by 7.6% in the second quarter. Bank of America Corp DE now owns 716,382 shares of the medical equipment provider’s stock valued at $172,089,000 after purchasing an additional 50,607 shares during the period. Hedge funds and other institutional investors own 94.69% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of analysts have recently issued reports on STE shares. Wall Street Zen raised STERIS from a “buy” rating to a “strong-buy” rating in a research note on Sunday, September 14th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of STERIS in a research note on Tuesday, October 14th. KeyCorp lifted their price target on STERIS from $277.00 to $288.00 and gave the stock an “overweight” rating in a research note on Tuesday, July 22nd. Finally, Morgan Stanley lifted their price target on STERIS from $276.00 to $295.00 and gave the stock an “overweight” rating in a research note on Friday, August 8th. Seven equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the stock. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $273.50.

STERIS Company Profile

STERIS plc provides infection prevention products and services worldwide. It operates through four segments: Healthcare, Applied Sterilization Technologies, Life Sciences, and Dental. The Healthcare segment offers cleaning chemistries and sterility assurance products; automated endoscope reprocessing system and tracking products; endoscopy accessories, washers, sterilizers, and other pieces of capital equipment for the operation of a sterile processing department; and equipment used directly in the operating room, including surgical tables, lights, and connectivity solutions, as well as equipment management services.